- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
Every Cure and Predictive Oncology Inc. formed a strategic collaboration to use AI for drug repurposing.
1 report, 1 independent
Updated Sep 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Every Cure and Predictive Oncology Inc. formed a strategic collaboration to use AI for drug repurposing.
Who's involved
What this event is mainly aboutKeep exploring
Part of
Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.Also in this story
- CRO Partner and NetraMark have formed a partnership to utilize artificial intelligence for the analysis of clinical trial data.
- HubRx AI integrates with leading Large Language Models (LLMs) to streamline prescription hub services.
- Viva Biotech and V-DEL are utilizing technology to support continuous drug discovery and target triage.
- Sino Biological, Inc. published research on AI protein design validation and listed on the Shenzhen Stock Exchange.
The entities involved
-
Every Cure
nonprofit organization in United Nations Headquarters, United States
- FDA
Related events
- FDA is willing to review updated submissions, while biotech hubs leverage AI to ease clinical development bottlenecks.
- Zenith collaborates with Harvard researchers on clinical studies, receiving FDA clearance for the trial.
- FDA, LabCorp, and Charles River Laboratories formed a collaboration to evaluate the potential for medicine abuse.
- Arise is seeking FDA approval for a drug as of October 7, 2026.
- FDA approved a new cancer drug in Massachusetts on October 21, 2026.
Coverage
Newest first; wire copies grouped- GlobeNewswirePredictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients Collaboration builds upon positive results utilizing Predictive Oncology’s AI plat